Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 3/20 | 0.74 |
| ▸ | GSK3B | P49841 | 3/20 | 0.44 |
| ▸ | CASP1 | P29466 | 2/20 | 0.44 |
| ▸ | CASP3 | P42574 | 2/20 | 0.44 |
| ▸ | CASP7 | P55210 | 2/20 | 0.44 |
| ▸ | CASP6 | P55212 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.44 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.44 |
| ▸ | UCHL1 | P09936 | 2/20 | 0.43 |
| ▸ | UCHL3 | P15374 | 2/20 | 0.43 |
| ▸ | CA2 | P00918 | 3/20 | 0.43 |
| ▸ | CA1 | P00915 | 2/20 | 0.43 |
| ▸ | CA4 | P22748 | 1/20 | 0.43 |
| ▸ | CA7 | P43166 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 2/20 | 0.41 |
| ▸ | CA9 | Q16790 | 2/20 | 0.41 |
| ▸ | TYR | P14679 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13627935 | 0.87 | ACHE (0.55) | ACHEGSK3BCASP1CASP3CASP7 | |
| SCHEMBL13627925 | 0.87 | ACHE (0.74) | ACHEGSK3BCASP1CASP3CASP7 | |
| SCHEMBL13627949 | 0.87 | ACHE (0.55) | ACHEGSK3BCASP1CASP3CASP7 | |
| SCHEMBL13627899 | 0.86 | ACHE (0.56) | ACHEGSK3BCASP1CASP3CASP7 | |
| SCHEMBL13627907 | 0.82 | CA1 (0.49) | ACHEALDH1A1ALDH2ALDH3A1UCHL1 | |
| SCHEMBL13627904 | 0.80 | ACHE (0.53) | ACHECASP1CASP3CASP7CASP6 | |
| SCHEMBL13627900 | 0.79 | ALDH1A1 (0.69) | ACHEALDH1A1ALDH2ALDH3A1UCHL1 | |
| SCHEMBL13627916 | 0.76 | CASP1 (0.51) | ACHECASP1CASP3CASP7CASP6 | |
| SCHEMBL13627910 | 0.73 | CASP1 (0.72) | ACHECASP1CASP3CASP7CASP6 | |
| SCHEMBL18954615 | 0.72 | ACHE (0.73) | ACHEGSK3BCASP1CASP3CASP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7612065-B2 | Inhibitors of c-JUN N-terminal kinases (JNK) | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2009-11-03 | — | — | US | disclosed |
| US-20080033022-A1 | Inhibitors of c-Jun N-terminal kinases (JNK) | SALITURO FRANCESCO G | 2008-02-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080033022-A1 | Inhibitors of c-Jun N-terminal kinases (JNK) | MAP3K1, JUN, MAP3K7 | ACHE 4079/4885GSK3B 266/4885CASP1 355/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.